世界中医药
文章摘要
引用本文:王安琪1,田莉娟1,陈晓鹏2,张静1,邹立伟1,杨凌1.清肺排毒汤对二肽基肽酶-Ⅳ的抑制作用研究[J].世界中医药,2022,(08):.  
清肺排毒汤对二肽基肽酶-Ⅳ的抑制作用研究
Inhibitory Effect of Qingfei Paidu Decoction on DPP-Ⅳ
投稿时间:2021-03-17  
DOI:10.3969/j.issn.1673-7202.2022.08.003
中文关键词:  二肽基肽酶-Ⅳ  抑制剂  2型糖尿病  清肺排毒汤  新型冠状病毒肺炎  芹菜素  槲皮素  山柰酚
English Keywords:DPP-Ⅳ  Inhibitor  Type 2 diabetes mellitus  Qingfei Paidu Decoction  COVID-19  Apigenin  Quercetin  Kaempferol
基金项目:国家重点研发计划项目“新冠肺炎应急项目”(2020YFC0845400);国家科技重大专项“重大新药创制”(2018ZX09731016-004);国家重点研发计划项目“中医药现代化研究”(2017YFC1702000)
作者单位
王安琪1,田莉娟1,陈晓鹏2,张静1,邹立伟1,杨凌1 1 上海中医药大学交叉科学研究院上海201203
2 江西省上饶市立医院普外科上饶334000 
摘要点击次数: 518
全文下载次数: 0
中文摘要:
      目的:以自主研发的二肽基肽酶-Ⅳ(DPP-Ⅳ)特异性双光子荧光探针甘氨酰-脯氨酰-N-丁基-4-氨基-1,8-萘二甲酰亚胺(GP-BAN)为底物,人血浆为DPP-Ⅳ酶原,评价方剂清肺排毒汤及处方中中药材对DPP-Ⅳ的抑制作用,并进一步评价具有DPP-Ⅳ抑制活性中药材的成分单体化合物。方法:以建立的DPP-Ⅳ抑制剂筛选体系,分别将清肺排毒汤汤剂的喷干粉水溶液、中药颗粒水溶液、中药单体化合物与DPP-Ⅳ特异性探针GP-BAN在37 ℃条件下共同孵育,通过测定探针底物代谢产物BAN的荧光值来判断上述物质对DPP-Ⅳ的抑制程度。结果:清肺排毒汤具有较弱的DPP-Ⅳ活性的抑制作用,而其组分中药水溶液浓度为1 000 μg/mL时,麻黄、枳实、广藿香颗粒水溶液对DPP-Ⅳ的活性明显的抑制作用,酶残余活性分别为40.00%、61.05%、62.04%。橙皮素、芦丁、芹菜素、槲皮素、山柰酚、去甲基麻黄碱、川陈皮素对DPP-Ⅳ有一定的抑制作用,其中最强的3种单体成分槲皮素、山柰酚及芹菜素对DPP-Ⅳ的IC50值分别为(75.39±6.17)μmol/L、(9.16±0.69)μmol/L和(7.91±1.09)μmol/L。结论:清肺排毒汤对DPP-Ⅳ的有一定的抑制作用,存在抑制DPP-Ⅳ的成分群和单体化合物,这些发现为“清肺排毒汤”对感染新型冠状病毒肺炎(COVID-19)患者,尤其是COVID-19合并T2DM的患者的治疗提供了参考。
English Summary:
      With the self-developed two-photon fluorescent probe glycyl-prolyl-N-butyl-4-amino-1,8-naphthalimide(GP-BAN) for dipeptidyl peptidase-Ⅳ(DPP-Ⅳ) detection with high specificity and sensitivity as the substrate and human plasma as the source of DPP-Ⅳ,this study aims to evaluate the inhibitory effect of Qingfei Paidu Decoction and the medicinals in the prescription on DPP-Ⅳ,and to further explore the effective compounds in the medicinals.Methods:With the established DPP-Ⅳ inhibitor screening system,the solution of Qingfei Paidu Decoction powder,the aqueous solution of the Chinese medicinal granules,and the effective compounds in the medicinals were respectively incubated with GP-BAN at 37 ℃.The inhibition on DPP-Ⅳ was evaluated based on the fluorescence value of the probe metabolite BAN.Results:Qingfei Paidu Decoction showed mild inhibitory effect on DPP-Ⅳ.The aqueous solution of Herba Ephedrae,Fructus Aurantii Immaturus,and Herba Pogostemonis granules at 1 000 μg/mL had obvious inhibitory effect on DPP-Ⅳ,and the residual activity of the enzyme was 40.00%,61.05%,and 62.04%,separately.Hesperetin,rutin,apigenin,quercetin,kaempferol,norephedrine,and nobiletin significantly suppressed DPP-Ⅳ,particularly quercetin,kaempferol,and apigenin whose half maximal inhibitory concentration(IC50) on DPP-Ⅳ was(75.39±6.17) μmol/L,(9.16±0.69) μmol/L,and(8.29±0.93) μmol/L,respectively.Conclusion:Qingfei Paidu Decoction inhibits DPP-Ⅳ,and the medicinals in the prescription and the compounds in the medicinals also show inhibitory effect on DPP-Ⅳ.These findings can serve as a reference for the treatment of coronavirus disease 2019(COVID-19) with Qingfei Paidu Decoction,especially COVID-19 complicated with type 2 diabetes mellitus(T2DM).
查看全文  查看/发表评论  下载PDF阅读器